Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

13/05/2022 06:50

May 13 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2022        Mar 31, 2021      Dec 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            193 mln             62 mln             1.00      
                                     (-10.9 pct)                    
  Operating     loss 384 mln        loss 349 mln        loss 1.60   
  Recurring     loss 349 mln        loss 349 mln        loss 1.60   
  Net           loss 328 mln        loss 350 mln        loss 1.60   
  EPS          loss 18.98 yen      loss 22.36 yen    loss 94.59 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T